Livent (LTHM) Stock

Livent and Allkem have now merged into a new top lithium company: Arcadium Lithium. On their own, Livent and Allkem were highly profitable.

In the latest trading session, Livent (LTHM) closed at $18.05, marking a +0.39% move from the previous day.

Zacks.com users have recently been watching Livent (LTHM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Livent (LTHM) closed at $16.44 in the latest trading session, marking a +0.92% move from the prior day.

The strong share price decline is a result of the macro headwinds in the lithium sector. 50% decline over the past 12 months. Despite these challenges, Livent's fundamental outlook remains strong, with anticipated growth in the lithium sector and a merger with Allkem as additional growth catalysts. Technical analysis shows a bottom around $13-$14.

Livent Corporation is a lithium products company that trades below its IPO price and has exposure to the promising lithium industry. The company's financial performance has been impacted in recent quarters by cyclicality, but it continues to improve its strategic positioning in the industry. LTHM's merger with Allkem is expected to bring synergies and diversification of assets, making it one of the world's largest lithium companies.

Zacks.com users have recently been watching Livent (LTHM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

The Global X Lithium & Battery Tech ETF (NYSEARCA: LIT ) shed over 15% of its market value since the turn of the year, suggesting the lithium industry is subject to systematic headwinds. Although lithium stocks have surrendered value, we need to put matters into perspective before committing to long-term investment decisions.

Zacks.com users have recently been watching Livent (LTHM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.